Research output per year
Research output per year
Search results
-
2019
SELPAC: A 3 arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel (PT) in metastatic uveal melanoma (UM)
Nathan, P., Needham, A., Corrie, P. G., Danson, S., Evans, J., Ochsenreither, S., Kumar, S., Goodman, A., Larkin, J. M. G., Karydis, I., Steven, N. M., Lorigan, P., Plummer, R., Patel, P., Shaw, H. M., Leyvraz, S., Rawcliffe, C., Psarelli, E. E., Handley, L. & Sacco, J. J., Oct 2019, In: Annals of Oncology. 30Research output: Contribution to journal › Meeting Abstract › peer-review
-
2007
Preliminary results of a phase I/II study of weekly or twice weekly bortezomib in combination with rituximab, in patients with follicular lymphoma, mantle cell lymphoma and Waldenstrom's macroglobulinaemia
Agathocleous, A., Rule, S., Johnson, P., Radford, J. A., Lafon, N., Hunter, H., Kerr, J. P., Neeson, S. M., Matthews, J., Strauss, S., Montoto, S., Rohatiner, A. Z. S. & Lister, T. A., 16 Nov 2007, In: Blood. 110, 11, p. 754A 1 p.Research output: Contribution to journal › Meeting Abstract › peer-review
-
2005
HuMax-CD20, a novel fully human anti-CD20 monoclonal antibody: Results of a phase I/II trial in relapsed or refractory follicular non-Hodgkins's lymphoma.
Hagenbeek, A., Plesner, T., Johnson, P., Pedersen, L., Walewski, J., Hellmann, A., Link, B., Robak, T., Wojtukiewicz, M., Pfreundschuh, M., Kneba, M., Engert, A., Sonneveld, P., Petersen, J. & Radford, J., 2005, In: Blood. 106, 11, p. 270B-270B 1 p.Research output: Contribution to journal › Meeting Abstract › peer-review
-
Phase I trial of BB-10901 (huN901-DM1) given daily by IV infusion for three consecutive days every three weeks in patients with SCLC and other CD56-positive solid tumors
Lorigan, P., Woll, P., O'Brien, M., Clinch, Y., Donaldson, K., Xie, H., Wunderli, P., Hutchison, J. & Fram, R., 15 Dec 2005, In: Clinical Cancer Research. 11, 24 (part 2), p. 9055S-9055S 1 p.Research output: Contribution to journal › Meeting Abstract › peer-review